| Ident. | Authors (with country if any) | Title |
|---|
| 002600 (2013) |
Sho Konno [Japon] ; Pillaiyar Thanigaimalai ; Takehito Yamamoto ; Kiyohiko Nakada ; Rie Kakiuchi ; Kentaro Takayama ; Yuri Yamazaki ; Fumika Yakushiji ; Kenichi Akaji ; Yoshiaki Kiso ; Yuko Kawasaki ; Shen-En Chen ; Ernesto Freire ; Yoshio Hayashi | Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety. |
| 002669 (2013) |
Ji-Young Park [Corée du Sud] ; Jang Hoon Kim ; Jung Min Kwon ; Hyung-Jun Kwon ; Hyung Jae Jeong ; Young Min Kim ; Doman Kim ; Woo Song Lee ; Young Bae Ryu | Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava. |
| 002672 (2013) |
Xue Wu Zhang [République populaire de Chine] | A combination of epitope prediction and molecular docking allows for good identification of MHC class I restricted T-cell epitopes. |
| 002693 (2013) |
Hyun Lee [États-Unis] ; Shuyi Cao ; Kirk E. Hevener ; Lena Truong ; Joseph L. Gatuz ; Kavankumar Patel ; Arun K. Ghosh ; Michael E. Johnson | Synergistic inhibitor binding to the papain-like protease of human SARS coronavirus: mechanistic and inhibitor design implications. |
| 002745 (2013) |
Pillaiyar Thanigaimalai [Japon] ; Sho Konno ; Takehito Yamamoto ; Yuji Koiwai ; Akihiro Taguchi ; Kentaro Takayama ; Fumika Yakushiji ; Kenichi Akaji ; Shen-En Chen ; Aurash Naser-Tavakolian ; Arne Schön ; Ernesto Freire ; Yoshio Hayashi | Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: design, synthesis, biological evaluation, and docking studies. |
| 002805 (2013) |
Li Feng [République populaire de Chine] ; Xiaoyu Liu [République populaire de Chine] ; Weiliang Zhu [République populaire de Chine] ; Fujiang Guo [République populaire de Chine] ; Yingchun Wu [République populaire de Chine] ; Rui Wang [République populaire de Chine] ; Kaixian Chen [République populaire de Chine] ; Cheng Huang [République populaire de Chine] ; Yiming Li [République populaire de Chine] | Inhibition of human neutrophil elastase by pentacyclic triterpenes. |
| 002846 (2014) |
Jun Wang [République populaire de Chine] ; Peng Zhan [République populaire de Chine] ; Zhenyu Li [République populaire de Chine] ; Huiqing Liu [République populaire de Chine] ; Erik De Clercq [Belgique] ; Christophe Pannecouque [Belgique] ; Xinyong Liu [République populaire de Chine] | Discovery of nitropyridine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors via a structure-based core refining approach. |
| 002861 (2014) |
Diwakar Rai [République populaire de Chine] ; Wenmin Chen ; Peng Zhan ; Hong Liu ; Ye Tian ; Xin Liang ; Erik De Clercq ; Christophe Pannecouque ; Jan Balzarini ; Xinyong Liu | Synthesis and anti-HIV activity of 4-(naphthalen-1-yl)-1,2,5-thiadiazol-3-hydroxyl derivatives. |
| 002878 (2014) |
Xiao Li [République populaire de Chine] ; Wenmin Chen [République populaire de Chine] ; Ye Tian [République populaire de Chine] ; Huiqing Liu [République populaire de Chine] ; Peng Zhan [République populaire de Chine] ; Erik De Clercq [Belgique] ; Christophe Pannecouque [Belgique] ; Jan Balzarini [Belgique] ; Xinyong Liu [République populaire de Chine] | Discovery of novel diarylpyrimidines as potent HIV NNRTIs via a structure-guided core-refining approach. |
| 002881 (2014) |
Tianlei Ying [Israël] ; Lanying Du [États-Unis] ; Tina W. Ju [États-Unis] ; Ponraj Prabakaran [États-Unis] ; Candy C Y. Lau [Hong Kong] ; Lu Lu [République populaire de Chine] ; Qi Liu [République populaire de Chine] ; Lili Wang [États-Unis] ; Yang Feng [États-Unis] ; Yanping Wang [États-Unis] ; Bo-Jian Zheng [États-Unis] ; Kwok-Yung Yuen [États-Unis] ; Shibo Jiang [République populaire de Chine] ; Dimiter S. Dimitrov [Israël] | Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies. |
| 002886 (2014) |
Adeyemi O. Adedeji [États-Unis] ; Kamalendra Singh [États-Unis] ; Ademola Kassim [États-Unis] ; Christopher M. Coleman [États-Unis] ; Ruth Elliott [États-Unis] ; Susan R. Weiss [États-Unis] ; Matthew B. Frieman [États-Unis] ; Stefan G. Sarafianos [États-Unis] | Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses. |
| 002905 (2015) |
Jingjing Gao [République populaire de Chine] ; Xianjin Luo ; Yuhuan Li ; Rongmei Gao ; Haifeng Chen ; Dingjue Ji | Synthesis and biological evaluation of 2-oxo-pyrazine-3-carboxamide-yl nucleoside analogues and their epimers as inhibitors of influenza A viruses. |
| 002992 (2015) |
Yuanyuan Cao [République populaire de Chine] ; Yu Zhang [République populaire de Chine] ; Shaotong Wu [République populaire de Chine] ; Quanzhi Yang [République populaire de Chine] ; Xuefeng Sun [République populaire de Chine] ; Jianxiong Zhao [République populaire de Chine] ; Fen Pei [République populaire de Chine] ; Ying Guo [République populaire de Chine] ; Chao Tian [République populaire de Chine] ; Zhili Zhang [République populaire de Chine] ; Haining Wang [République populaire de Chine] ; Liying Ma [République populaire de Chine] ; Junyi Liu [République populaire de Chine] ; Xiaowei Wang [République populaire de Chine] | Synthesis and biological evaluation of pyridinone analogues as novel potent HIV-1 NNRTIs. |
| 002A16 (2014) |
Yasuhiro Shimamoto [Japon] ; Yasunao Hattori [Japon] ; Kazuya Kobayashi [Japon] ; Kenta Teruya [Japon] ; Akira Sanjoh [Japon] ; Atsushi Nakagawa [Japon] ; Eiki Yamashita [Japon] ; Kenichi Akaji [Japon] | Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors |
| 002A58 (2015) |
Sheng Liu [République populaire de Chine] ; Wanxing Wei [République populaire de Chine] ; Yubin Li [République populaire de Chine] ; Xu Liu [République populaire de Chine] ; Xiaoji Cao [République populaire de Chine] ; Kechan Lei [République populaire de Chine] ; Min Zhou [République populaire de Chine] | Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents. |
| 002A66 (2015) |
Sanjeev Kumar V. Vernekar [États-Unis] ; Li Qiu [États-Unis] ; Jing Zhang [États-Unis] ; Jayakanth Kankanala [États-Unis] ; Hongmin Li [États-Unis] ; Robert J. Geraghty [États-Unis] ; Zhengqiang Wang [États-Unis] | 5′-Silylated 3′-1,2,3-triazolyl Thymidine Analogues as Inhibitors of West Nile Virus and Dengue Virus |
| 002A86 (2015) |
Sakshi Tomar ; Melanie L. Johnston [États-Unis] ; Sarah E. St John ; Heather L. Osswald [États-Unis] ; Prasanth R. Nyalapatla [États-Unis] ; Lake N. Paul ; Arun K. Ghosh [États-Unis] ; Mark R. Denison [États-Unis] ; Andrew D. Mesecar [États-Unis] | Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS. |
| 002B74 (2015) |
Michael Berry [Afrique du Sud] ; Burtram C. Fielding [Afrique du Sud] ; Junaid Gamieldien [Afrique du Sud] | Potential Broad Spectrum Inhibitors of the Coronavirus 3CLpro: A Virtual Screening and Structure-Based Drug Design Study. |
| 002B87 (2016) |
Jiapei Yang [République populaire de Chine] ; Wenmin Chen [République populaire de Chine] ; Dongwei Kang [République populaire de Chine] ; Xueyi Lu [République populaire de Chine] ; Xiao Li [République populaire de Chine] ; Zhaoqiang Liu [République populaire de Chine] ; Boshi Huang [République populaire de Chine] ; Dirk Daelemans [Belgique] ; Christophe Pannecouque [Belgique] ; Erik De Clercq [Belgique] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] | Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket. |
| 002C03 (2016) |
Hiroyuki Konno [Japon] ; Masaki Wakabayashi [Japon] ; Daiki Takanuma [Japon] ; Yota Saito [Japon] ; Kenichi Akaji [Japon] | Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease |
| 002C25 (2016) |
Sheng Liu [République populaire de Chine] ; Yubin Li [République populaire de Chine] ; Wanxing Wei [République populaire de Chine] ; Kuiwu Wang [République populaire de Chine] ; Lisheng Wang [République populaire de Chine] ; Jianyi Wang [République populaire de Chine] | Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives. |
